OrbiMed Capital GP IV LLC insider trades: TELA Bio (TELA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where OrbiMed Capital GP IV LLC reports to the SEC
and 6 more companies
Open-market buys and sales
55 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | TELA | ↓ Sell | 428,300 | $4.72 | $2.0M | Indirect | Jul 2, 2024 (0d) |
| Apr 21, 2023 | TELA | ↓ Sell | 192,000 | $9.34 | $1.8M | Indirect | Apr 21, 2023 (0d) |
| Jul 19, 2021 | AFIB | ↑ Buy | 1,071,428 | $14.00 | $15.0M | Indirect | Jul 21, 2021 (2d) |
| Aug 10, 2020 | AFIB | ↑ Buy | 415,000 | $18.00 | $7.5M | Indirect | Aug 12, 2020 (2d) |
| Apr 16, 2020 | ALEC | ↓ Sell | 85,414 | $23.53 | $2.0M | Indirect | Apr 16, 2020 (0d) |
| Apr 9, 2020 | ALEC | ↓ Sell | 379,885 | $23.74 | $9.0M | Indirect | Apr 9, 2020 (0d) |
| Mar 31, 2020 | ALEC | ↓ Sell | 250,000 | $24.50 | $6.1M | Indirect | Apr 2, 2020 (2d) |
| Mar 25, 2020 | ALEC | ↓ Sell | 138,653 | $24.70 | $3.4M | Indirect | Mar 25, 2020 (0d) |
| Mar 2, 2020 | ALEC | ↓ Sell | 1,874,203 | $26.00 | $48.7M | Indirect | Mar 4, 2020 (2d) |
| Jan 9, 2020 | ALEC | ↓ Sell | 379,997 | $19.50 | $7.4M | Indirect | Jan 13, 2020 (4d) |
| Dec 26, 2019 | ALEC | ↓ Sell | 519,385 | $19.66 | $10.2M | Indirect | Dec 26, 2019 (0d) |
| Dec 17, 2019 | ALEC | ↓ Sell | 954,100 | $18.52 | $17.7M | Indirect | Dec 19, 2019 (2d) |
| Nov 8, 2019 | TELA | ↑ Buy | 384,615 | $13.00 | $5.0M | Direct | Nov 13, 2019 (5d) |
| Aug 7, 2019 | ALEC | ↓ Sell | 650,000 | $17.90 | $11.6M | Indirect | Aug 9, 2019 (2d) |
| May 21, 2019 | PRNB | ↓ Sell | 1,000,000 | $30.25 | $30.3M | Indirect | May 22, 2019 (1d) |
| Feb 11, 2019 | ALEC | ↑ Buy | 411,700 | $19.00 | $7.8M | Indirect | Feb 11, 2019 (0d) |
| Sep 18, 2018 | PRNB | ↑ Buy | 250,000 | $17.00 | $4.3M | Indirect | Sep 20, 2018 (2d) |
| Mar 12, 2018 | BOLD | ↓ Sell | 156,431 | $34.97 | $5.5M | Indirect | Mar 12, 2018 (0d) |
| Mar 6, 2018 | BOLD | ↓ Sell | 433,210 | $35.11 | $15.2M | Indirect | Mar 6, 2018 (0d) |
| Sep 29, 2017 | BOLD | ↓ Sell | 672,000 | $28.25 | $19.0M | Indirect | Sep 29, 2017 (0d) |
| Sep 7, 2017 | BOLD | ↓ Sell | 5,000 | $22.35 | $112K | Indirect | Sep 11, 2017 (4d) |
| Jul 25, 2016 | RLYP | ↓ Sell | 4,043,600 | $32.00 | $129.4M | Indirect | Jul 26, 2016 (1d) |
| Dec 23, 2015 | RLYP | ↓ Sell | 500,000 | $27.18 | $13.6M | Indirect | Dec 23, 2015 (0d) |
| Nov 30, 2015 | OTIC | ↓ Sell | 67,106 | $28.93 | $1.9M | Indirect | Nov 30, 2015 (0d) |
| Nov 24, 2015 | OTIC | ↓ Sell | 200,800 | $28.56 | $5.7M | Indirect | Nov 24, 2015 (0d) |
| Nov 19, 2015 | OTIC | ↓ Sell | 138,398 | $28.62 | $4.0M | Indirect | Nov 19, 2015 (0d) |
| Oct 22, 2015 | RLYP | ↑ Buy | 500,000 | $12.56 | $6.3M | Indirect | Oct 22, 2015 (0d) |
| May 18, 2015 | RLYP | ↓ Sell | 1,457,551 | $34.13 | $49.7M | Indirect | May 20, 2015 (2d) |
| Mar 26, 2015 | ICPT | ↓ Sell | 157,200 | $286.75 | $45.1M | Indirect | Mar 30, 2015 (4d) |
| Mar 25, 2015 | ICPT | ↓ Sell | 207,800 | $274.41 | $57.0M | Indirect | Mar 25, 2015 (0d) |
| Feb 3, 2015 | MRTX | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Feb 5, 2015 (2d) |
| Sep 17, 2014 | RLYP | ↓ Sell | 94,000 | $25.27 | $2.4M | Indirect | Sep 18, 2014 (1d) |
| Aug 26, 2014 | ICPT | ↓ Sell | 111,258 | $298.06 | $33.2M | Indirect | Aug 27, 2014 (1d) |
| Aug 18, 2014 | OTIC | ↑ Buy | 171,875 | $16.00 | $2.8M | Indirect | Aug 19, 2014 (1d) |
| Aug 15, 2014 | RLYP | ↓ Sell | 990,000 | $26.35 | $26.1M | Indirect | Aug 19, 2014 (4d) |
| Aug 14, 2014 | ICPT | ↓ Sell | 60,000 | $299.82 | $18.0M | Indirect | Aug 18, 2014 (4d) |
| Jul 1, 2014 | MRTX | ↓ Sell | 107,332 | $21.66 | $2.3M | Indirect | Jul 1, 2014 (0d) |
| Apr 9, 2014 | ICPT | ↓ Sell | 81,305 | $320.00 | $26.0M | Indirect | Apr 11, 2014 (2d) |
| Nov 20, 2013 | RLYP | ↑ Buy | 712,192 | $11.00 | $7.8M | Indirect | Nov 20, 2013 (0d) |
| Oct 29, 2013 | MRTX | ↑ Buy | 125,000 | $17.50 | $2.2M | Indirect | Oct 31, 2013 (2d) |
| Oct 21, 2013 | ICPT | ↓ Sell | 40,088 | $62.50 | $2.5M | Indirect | Oct 23, 2013 (2d) |
| Oct 15, 2013 | ICPT | ↓ Sell | 376,585 | $62.50 | $23.5M | Indirect | Oct 17, 2013 (2d) |
| Jan 30, 2013 | ANTH | ↑ Buy | 5,700,000 | $0.66 | $3.8M | Indirect | Feb 1, 2013 (2d) |
| Jan 25, 2013 | ANTH | ↑ Buy | 1,762,000 | $0.65 | $1.1M | Indirect | Jan 29, 2013 (4d) |
| Oct 16, 2012 | ICPT | ↑ Buy | 333,334 | $15.00 | $5.0M | Indirect | Oct 16, 2012 (0d) |
| Jun 29, 2012 | ANTH | ↓ Sell | 1,283,300 | $0.73 | $942K | Indirect | Jul 3, 2012 (4d) |
| Mar 22, 2012 | ANTH | ↓ Sell | 1,548,500 | $2.48 | $3.8M | Indirect | Mar 22, 2012 (0d) |
| Dec 13, 2011 | ANTH | ↓ Sell | 56,200 | $6.68 | $375K | Indirect | Dec 13, 2011 (0d) |
| Nov 18, 2011 | ANTH | ↓ Sell | 52,000 | $6.76 | $351K | Indirect | Nov 18, 2011 (0d) |
| Nov 15, 2011 | ANTH | ↓ Sell | 60,000 | $6.95 | $417K | Indirect | Nov 15, 2011 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TELA insiders
Open-market trades in the last 12 months
About OrbiMed Capital GP IV LLC's insider trades
OrbiMed Capital GP IV LLC is a 10% owner of TELA Bio (TELA). Since Sep 30, 2010, it has reported 14 open-market purchases worth $70.6M and 41 sales worth $640.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (9 filings), option exercises (9 filings), other transactions (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TELA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.